We are live on ! Find out more
SIA

Sit Investment Associates Portfolio holdings

AUM $4.93B
1-Year Est. Return 12.22%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+12.22%
3 Year Est. Return
+41.16%
5 Year Est. Return
+31.78%
10 Year Est. Return
+136.16%
AUM
$5.88B
AUM Growth
+$182M
Cap. Flow
-$13.4M
Cap. Flow %
-0.23%
Top 10 Hldgs %
15.96%
Holding
484
New
37
Increased
116
Reduced
183
Closed
43

Top Buys

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$42.5M
2
APTV icon
Aptiv
APTV
+$35.8M
3
AET
Aetna Inc
AET
+$31.2M
4
DVN icon
Devon Energy
DVN
+$30.7M
5
ADM icon
Archer Daniels Midland
ADM
+$28.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.35%
2 Industrials 14.27%
3 Technology 13.02%
4 Financials 11.39%
5 Energy 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBD icon
301
Banco Bradesco
BBD
$36.7B
$1.72M 0.03%
302,123
WFC icon
302
Wells Fargo
WFC
$264B
$1.69M 0.03%
32,145
-350
-1% -$17.6K
GEVA
303
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$1.65M 0.03%
15,755
NAC icon
304
Nuveen California Quality Municipal Income Fund
NAC
$1.85B
$1.65M 0.03%
+117,989
New +$1.66M
XOM icon
305
ExxonMobil
XOM
$634B
$1.64M 0.03%
16,282
LFC
306
DELISTED
China Life Insurance Company Ltd.
LFC
$1.64M 0.03%
125,100
TRAK
307
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$1.6M 0.03%
+35,330
New +$1.53M
CBD
308
DELISTED
Companhia Brasileira de Distribuicao
CBD
$1.57M 0.03%
34,000
-4,050
-11% -$190K
PBYI icon
309
Puma Biotechnology
PBYI
$454M
$1.52M 0.03%
23,065
JAZZ icon
310
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.51M 0.03%
10,300
KO icon
311
Coca-Cola
KO
$375B
$1.46M 0.02%
34,400
-210,145
-86% -$8.53M
TW
312
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$1.45M 0.02%
13,900
AMCX icon
313
AMC Global Media
AMCX
$489M
$1.41M 0.02%
22,900
+6,900
+43% +$441K
MXA
314
DELISTED
MINNESOTA MUNI INCM PTFL INC
MXA
$1.37M 0.02%
83,329
-13,510
-14% -$226K
BBK
315
DELISTED
Blackrock Municipal Bond Trust
BBK
$1.37M 0.02%
86,865
-147,520
-63% -$2.26M
ICE icon
316
Intercontinental Exchange
ICE
$84.4B
$1.36M 0.02%
36,000
VRTX icon
317
Vertex Pharmaceuticals
VRTX
$126B
$1.34M 0.02%
14,200
MZF
318
DELISTED
Managed Duration Inv Grd Muni Fd
MZF
$1.33M 0.02%
96,371
-43,944
-31% -$589K
IDXX icon
319
Idexx Laboratories
IDXX
$46.2B
$1.28M 0.02%
19,200
-7,600
-28% -$483K
INDA icon
320
iShares MSCI India ETF
INDA
$6.63B
$1.28M 0.02%
+43,000
New +$1.21M
GE icon
321
GE Aerospace
GE
$384B
$1.27M 0.02%
10,120
-7,229
-42% -$919K
JPC icon
322
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
$1.27M 0.02%
131,080
-181,653
-58% -$1.73M
PBH icon
323
Prestige Consumer Healthcare
PBH
$2.6B
$1.27M 0.02%
37,486
-84,279
-69% -$2.7M
JWN
324
DELISTED
Nordstrom
JWN
$1.24M 0.02%
18,300
CPN
325
DELISTED
Calpine Corporation
CPN
$1.23M 0.02%
51,500

Similar funds

Sit Investment Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Sit Investment Associates held 484 positions worth $5.88B, up 3.2% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Sit Investment Associates's Q2 2014 filing shows 37 new, 116 increased, 183 reduced and 43 closed positions. Its largest new stake was St Jude Medical: 655,425 shares worth $45.4M. The largest sale was Stryker, an estimated $45.2M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • Sit Investment Associates's largest Q2 2014 buy was St Jude Medical: 655,425 shares worth $45.4M.
  • Sit Investment Associates added most to Devon Energy in Q2 2014, an estimated $30.7M increase.
  • Sit Investment Associates's biggest Q2 2014 reduction was Stryker, cutting an estimated $45.2M.
  • Sit Investment Associates fully exited Public Storage in Q2 2014, selling an estimated $16.9M.
  • Sit Investment Associates's ten largest holdings make up 16% of its $5.88B portfolio in Q2 2014.
  • Sit Investment Associates opened 37 new positions and closed 43 in Q2 2014.
  • Sit Investment Associates's portfolio value rose 3.2% quarter-over-quarter to $5.88B.

Based on Sit Investment Associates's 13F filing for Q2 2014, filed 13 Aug 2014.